Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.023 | 0.7 |